Answers are grounded in this paper and cite their sources.
Pre-clinical studies support a Chagas disease vaccine, highlighting potential for combined drug and vaccine strategies.
Pre-clinical studies broadly support the clinical development of a Chagas disease vaccine, particularly for a therapeutic vaccine. Synergy with drug development efforts, which face many of the same challenges, may provide new opportunities to strengthen clinical development and trials of drugs, vaccines and combined therapies.
No takes yet. Share an insight, caveat, or question.
Dumonteil et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: